Aclaris Therapeutics, Inc.
Aclaris Therapeutics develops small-molecule and biologic product candidates for immuno-inflammatory diseases.
SCHEDULE 13GSep 21Latest SEC filing
Aug 6Latest story
Sign inSign inAclaris Therapeutics develops small-molecule and biologic product candidates for immuno-inflammatory diseases.